Trial Profile
A retrospective, long-term safety and efficacy study of repeated Dexamethasone (Ozurdex) injections in patients with macular edema after retinal vein occlusion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Feb 2017
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- Acronyms REMIDO 2
- 14 Feb 2017 New trial record